Primary Resistance to First- and Second-Generation ALK Inhibitors in a Non-Small Cell Lung Cancer Patient with Coexisting ALK Rearrangement and an ALK F1174L-cis-S1189C De Novo Mutation: A Case Report
Frontiers in pharmacology（2022）
关键词
non-small cell lung cancer (NSCLC),next generation sequencing (NGS),EML4-ALK,F1174L,S1189C,de novo mutation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要